These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 22272488)
21. Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice. Romero R; Stanczyk FZ Am J Obstet Gynecol; 2013 Jun; 208(6):421-6. PubMed ID: 23643669 [No Abstract] [Full Text] [Related]
22. Vaginal Progesterone Is Associated with Intrahepatic Cholestasis of Pregnancy. Tsur A; Leonard SA; Kan P; Datoc IA; Girsen AI; Shaw GM; Stevenson DK; El-Sayed YY; Druzin ML; Blumenfeld YJ Am J Perinatol; 2023 Aug; 40(11):1158-1162. PubMed ID: 37100422 [TBL] [Abstract][Full Text] [Related]
23. Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial. Rozenberg P; Chauveaud A; Deruelle P; Capelle M; Winer N; Desbrière R; Perrotin F; Bohec C; Connan L; Vayssière C; Langer B; Mantel A; Azimi S; Porcher R; Azria E; Am J Obstet Gynecol; 2012 Mar; 206(3):206.e1-9. PubMed ID: 22381603 [TBL] [Abstract][Full Text] [Related]
24. [Progesterone for prevention of preterm delivery: only in trial setting]. Lim AC; Mol BW; Bruinse HW Ned Tijdschr Geneeskd; 2010; 154():A1730. PubMed ID: 20858311 [TBL] [Abstract][Full Text] [Related]
26. Use of hydroxyprogesterone caproate to prevent preterm labour in uterine didelphys: a case report. Ng KS; Ng BK; Lim PS; Shafiee MN; Abdul Karim AK; Omar MH Horm Mol Biol Clin Investig; 2016 Sep; 27(3):89-91. PubMed ID: 26684353 [TBL] [Abstract][Full Text] [Related]
27. Effect of 17alpha-hydroxyprogesterone caproate on glucose intolerance in pregnancy. Waters TP; Schultz BAH; Mercer BM; Catalano PM Obstet Gynecol; 2009 Jul; 114(1):45-49. PubMed ID: 19546757 [TBL] [Abstract][Full Text] [Related]
28. Optimal routes of administration, vehicles and timing of progesterone treatment for inhibition of delivery during pregnancy. Fang D; Moreno M; Garfield RE; Kuon R; Xia H Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():164-168. PubMed ID: 28777967 [TBL] [Abstract][Full Text] [Related]
30. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate. Yemini M; Borenstein R; Dreazen E; Apelman Z; Mogilner BM; Kessler I; Lancet M Am J Obstet Gynecol; 1985 Mar; 151(5):574-7. PubMed ID: 3976757 [TBL] [Abstract][Full Text] [Related]
31. Regulation of progesterone signaling during pregnancy: implications for the use of progestins for the prevention of preterm birth. Byrns MC J Steroid Biochem Mol Biol; 2014 Jan; 139():173-81. PubMed ID: 23410596 [TBL] [Abstract][Full Text] [Related]
32. Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo. Klebanoff MA; Meis PJ; Dombrowski MP; Zhao Y; Moawad AH; Northen A; Sibai BM; Iams JD; Varner MW; Caritis SN; O'Sullivan MJ; Leveno KJ; Miodovnik M; Conway D; Wapner RJ; Carpenter M; Mercer BM; Ramin SM; Thorp JM; Peaceman AM; Am J Obstet Gynecol; 2008 Nov; 199(5):506.e1-7. PubMed ID: 18456237 [TBL] [Abstract][Full Text] [Related]
33. Recurrent hope for the treatment of preterm delivery. Doggrell SA Expert Opin Pharmacother; 2003 Dec; 4(12):2363-6. PubMed ID: 14640934 [TBL] [Abstract][Full Text] [Related]
34. Prophylactic use of hydroxyprogesterone caproate in abdominal surgery during pregnancy. A retrospective evaluation. Hill LM; Johnson CE; Lee RA Obstet Gynecol; 1975 Sep; 46(3):287-90. PubMed ID: 1161231 [TBL] [Abstract][Full Text] [Related]
35. 17-α hydroxyprogesterone caproate for the prevention of preterm birth. Gupta S; Roman AS Womens Health (Lond); 2012 Jan; 8(1):21-30. PubMed ID: 22171770 [TBL] [Abstract][Full Text] [Related]
36. 17α-hydroxyprogesterone caproate access in the Louisiana Medicaid population. Orsulak MK; Block-Abraham D; Gee RE Clin Ther; 2015 Apr; 37(4):727-32. PubMed ID: 25700945 [TBL] [Abstract][Full Text] [Related]
37. 17alpha-hydroxy-progesterone effects on cervical proinflammatory agents in women at risk for preterm delivery. Facchinetti F; Dante G; Venturini P; Paganelli S; Volpe A Am J Perinatol; 2008 Sep; 25(8):503-6. PubMed ID: 18756431 [TBL] [Abstract][Full Text] [Related]
38. The effect of 17α-hydroxyprogesterone caproate on preterm birth in women with an ultrasound-indicated cerclage. Rafael TJ; Mackeen AD; Berghella V Am J Perinatol; 2011 May; 28(5):389-94. PubMed ID: 21380984 [TBL] [Abstract][Full Text] [Related]
39. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. Rouse DJ; Caritis SN; Peaceman AM; Sciscione A; Thom EA; Spong CY; Varner M; Malone F; Iams JD; Mercer BM; Thorp J; Sorokin Y; Carpenter M; Lo J; Ramin S; Harper M; Anderson G; N Engl J Med; 2007 Aug; 357(5):454-61. PubMed ID: 17671253 [TBL] [Abstract][Full Text] [Related]
40. Trends in prematurity: what do changes at an urban institution suggest about the public health impact of 17-alpha hydroxyprogesterone caproate? Bastek JA; Adamczak JE; Hoffman S; Elovitz MA; Srinivas SK Matern Child Health J; 2012 Apr; 16(3):564-8. PubMed ID: 21484515 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]